logo

Recovery with global economy in 25-26

KG
kgmaik89Not Invested
Community Contributor
Published
03 Jul 24
Updated
25 Jul 24
Share
kgmaik89's Fair Value
€80.94
28.0% undervalued intrinsic discount
25 Jul
€58.24
Loading
1Y
-22.2%
7D
5.1%

Author's Valuation

€80.9

28.0% undervalued intrinsic discount

kgmaik89's Fair Value

Gewinnwarnung 2024:

  • Gestiegende Transportkosten
  • Preissensititivät d. Kunden
  • Geringes Wirtschaftswachstum 2-4 % CAGR
  • "Low End of Guidance hard to achive"
  • Gewinnwarnungen auch von Produzenten BASF, Lanxess, Evonik
  • Umsatzwachstum "nur" 5,1 % (< erwartete 9...10%)
  • stagnierender Marktausblick Chemieindustrie (gestiegende Energiekosten), ggf. Verbesserung H2 2024 erwartet: stiegendes Handelsvolumen (?)
  • Markterholung Chemie (mit Weltwirtschaft) ab 2025-26
  • Geschäftsfeld Essentials resilienter
  • Upside: profitables Händlergeschäftsmodell (4-5 % Marge), starke Dividende, langfristiger Wachstumsmarkt, hohe Liquidität, finanzielle Stabilität, Marktführschaft (5%)
  • Downside: direkte Abhängigkeit von Weltwirtschaft/Wachstum Industrie/Chemie etc
  • Bewertungsabschlag da nicht auf Spezialchemie fokusiert --> Trennung Geschäftsfelder: https://themarket.ch/analyse/wie-brenntag-ihren-bewertungsabschlag-zur-konkurrenz-beseitigen-moechte-ld.11638

How well do narratives help inform your perspective?

Disclaimer

The user kgmaik89 holds no position in XTRA:BNR. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives